Skip to main content
. 2017 Apr 19;7:46458. doi: 10.1038/srep46458

Table 2. Factors associated with liver stiffness measurement ≥8.0 kPa in univariate and multivariate analyses.

Variables Univariate analysis P Value Multivriate analysis P Value
OR (95% CI) OR (95% CI)
Age, years 1.03 (1.01–1.05) <0.001 1.01 (0.99–1.03) 0.48
Male 1.64 (1.13–2.37) 0.009 2.16 (1.29–3.63) 0.004
BMI
 Normal; BMI <24 (kg/m2) 1.00 (reference)   1.00 (reference)  
 Overweight; 24 ≤ BMI < 30 (kg/m2) 1.43 (0.96–2.15) 0.079 2.31 (1.35–3.94) 0.002
 Obese; BMI ≥30 (kg/m2) 1.39 (0.43–4.45) 0.582 3.67 (0.97–13.96) 0.06
 Presence of HBV or HCV (%) 1.80 (1.21–2.69) 0.004 1.53 (0.95–2.47) 0.08
 DM (%) 1.13 (0.77–1.66) 0.531 0.63 (0.38–1.03) 0.06
 AST (IU/L) 1.08 (1.05–1.10) <0.001 1.08 (1.04–1.12) <0.001
 ALT (IU/L) 1.03 (1.01–1.04) <0.001 0.99 (0.96–1.01) 0.27
 Bilirubin (mg/dL) 1.16 (0.81–1.67) 0.418 1.14 (0.75–1.72) 0.54
 Albumin (mg/dL) 0.16 (0.09–0.29) <0.001 0.25 (0.12–0.53) <0.001
 Creatinine (mg/dL) 0.89 (0.82–0.96) 0.002 0.89 (0.79–1.00) 0.05
 Platelet (109/L) 0.99 (0.99–0.99) <0.001 0.99 (0.99–1.00) <0.001
 HDL-C: <40 mg/dL(male) or <50 mg/dL(female) 1.47 (1.02–2.12) 0.039 1.52 (0.91–2.55) 0.11
 LDL (mg/dL) 0.99 (0.98–1.00) 0.002 1.00 (0.99–1.02) 0.76
 Triglyceride >150 (mg/dL) 0.79 (0.53–1.17) 0.241 0.95 (0.52–1.74) 0.88
 Total cholesterol (mg/dL) 0.99 (0.98–0.99) <0.001 1.00 (0.99–1.01) 0.61
Steatosis
 No Steatosis (CAP <232.5) (dB/m) 1.00 (reference)   1.00 (reference)  
 Steatosis grade 1 (232.5 ≥CAP <255) (dB/m) 0.72 (0.43–1.21) 0.215 0.80 (0.43–1.48) 0.47
 Steatosis grade 2 (255 ≥ CAP <290) (dB/m) 0.91 (0.54–1.53) 0.731 1.07 (0.57–2.04) 0.83
 Steatosis grade3 (≥290) (dB/m) 1.45 (0.86–2.46) 0.167 1.79 (0.88–3.62) 0.11

BMI, body mass index; DM, diabetes mellitus; ALT, alanine aminotransferase; AST, aspartate aminotransferase; HDL, High-density lipoprotein; LDL, Low-density lipoprotein; CAP, Controlled Attenuation Parameter; HBV, hepatitis B virus; HCV, hepatitis C virus.